Is durvalumab the solution for unresectable stage III non-small cell lung cancer?

Narjust Duma, Aaron S. Mansfield

Abstract

Lung cancer is the leading cause of cancer deaths in the United States and worldwide (1). The majority of patients with newly diagnosed non-small cell lung cancers (NSCLC) have metastasis at presentation but a large group of patients present with locally or regionally advanced disease.